Hutch News

Hutch News

Stories tagged 'immune cells'

Immune cells share their insides with tumors to promote cancer spread

New study in zebrafish and mice shows immune cells interact with melanoma and transfer their contents to spur metastasis

Dec. 4, 2017 | By Rachel Tompa / Fred Hutch News Service

A new study using mice and tiny transparent fish as models of human cancer, published in Developmental Cell, has shed light on the very first stages of metastasis in the skin cancer melanoma.

View story >

Good News at Fred Hutch

Celebrating faculty and staff achievements

Sept. 16, 2016

Hyundai Hope on Wheels gives $250K grant for pediatric cancer research; Drs. Amanda Paulovich and Jeff Whiteaker facilitate "first step" in expanding NCI’s Protein Assay Portal.

View story >

After chemotherapy, immune system recovery may be slower than believed

Chemo weakens the immune system for up to nine months, especially in smokers, one study finds

Jan. 26, 2016 | By Diane Mapes / Fred Hutch News Service

A small observational study out of the U.K. of breast cancer patients found that certain types of chemotherapy can weaken part of the immune system for up to nine months after treatment.

View story >

Genital herpes-suppressing immune cells identified

Discovery by Fred Hutchinson Cancer Research Center’s Dr. Larry Corey and colleagues has implications for development of vaccine to prevent and treat HSV-2, similar infections

May 9, 2013 | By Dean Forbes

View story >

Hohl named Infectious Diseases Society fellow

Vaccine and Infectious Disease Division fungal expert Dr. Tobias Hohl among 86 physicians, scientists honored nationally

Nov. 19, 2012

View story >

Video: How HIV infects those with healed herpes lesions

Research led by Larry Corey of the Vaccine and Infectious Disease Institute explains why even treated genital herpes sores boost the risk of HIV infection

Aug. 3, 2009

Scientists, led by Drs. Lawrence Corey and Jia Zhu, of the Fred Hutchinson Cancer Research Center, and Dr. Anna Wald, of the University of Washington, uncovered details of an immune-cell environment conducive to HIV infection that persists at the location of HSV-2 genital skin lesions long after they have been treated with oral doses of the drug acyclovir and have healed and the skin appears normal. The findings appear in the Aug. 2 advance online edition of Nature Medicine.

View story >

(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks


Support our quest for cures

Story Archive


Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers

Fred Hutch News

        Get updates via email.